Grey Wolf Therapeutics is a startup based in the United States, most recent round Seed, 3 tracked investors.
Based in the United States, Grey Wolf Therapeutics is a startup founded in 2019. Its most recent tracked round is Seed. Brouky records 3 investors associated with the company.
Grey Wolf Therapeutics is a drug discovery company focused on developing novel therapeutics for cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.